Positive and Negative CatalystsOk, I've had my fun for the week so it's time to be serious. Like me, many of you got into TLT last spring based on a 4 month flurry of interviews and press releases. Most of you understand how foolish these recent posters are about $1 by Christmas, $5 by end 2015. We saw these same posts earlier this year! Caveat: Also understand that I think there is a small chance that a biotech may gamble and try to work a significant deal in 2015 based on: a.) Excellent rat confirmation results from U of T (hopefully within next 30 days) followed quickly by the identical rat trial at Princess M. b. Very early Ph1/2a human results on the 1st 3 or 4 of 30 total enrollees. If I understood discussion 6 months ago, TLT is able to release preliminary Ph1 results as rec'd... not at trial completion. THIS STATEMENT ON Ph1/2a EARLY RELEASE DATA NEEDS TO BE CONFIRMED AS IT WAS NOT MINE. With stock price slippage now , we should try to understand why! The short answer is that TLT will move based on catalysts. What are these catalysts? What are the FACTS (I love FACTS.. not trying to be funny here )! Catalyst 1.) Near term revenue stream: This is almost entirely defined by the TLC2000 sales. Mr. White's statement 5 months ago on the ph1/2a funding was that he had enough cash to start the ph1/2a trial but not finish it. That statement was predicated on sales in 4th quarter per Zack's report which we now know will not be realized. So, quite simply, a shareholder update on HC approval would be appreciated! Catalyst 2.) U of T and Princess M rat data details. Depending on how they present these data/results to the public/media, this has the potential to be a huge catalyst. Let's hope next 30 days on both with good presentation. Catalyst 3.) Mid- Term Financing: This has the potential to be a huge negative but maybe not necessarily. We can handle another sp dilution back to $0.30 (and it may go lower but so what if they can outline a plan that factually brings us to the 1st human being injected/lit up with PDC/laser)! No one here will like that dilution but it likely will be necessary (hopefully they are discussing other funding options w/biotech or government for the $5- 10 million needed). In any case, when we wake up to the surprise financing in 1st q, 2015, don't be surprised. If explained well, and if TLT is more open with shareholders, then this will be better digested. Catalyst 4: The PH1/2a Realistic Start- As you are aware there have been changing starts. In early 2014 when I started acquisition, this was to be 4th q, 2014. I won't rehash my feelings on this (I know crazy says TLT originally stated 2011 but I wasn't here then and I think he is still holding shares at $1 or above which is maybe why he is so bitter). I'm not so much negative as I want the truth (and please skip the Tom Cruise line about how "I can't handle the truth"! So, in short, wouldn't January 2nd be an ideal time for Mr. White to address his shareholders with a PR and hold our hand thru an updated 2015 schedule thru to Ph1/2a start? I think so!